• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

AMO introduces next-generation, one-piece IOL in the United States

Article

Advanced Medical Optics (AMO) announced the U.S. introduction of its next-generation, one-piece IOL (Tecnis) with design enhancements that target zero spherical aberration and improve night-driving simulator performance, according to the company.

Advanced Medical Optics (AMO) announced the U.S. introduction of its next-generation, one-piece IOL (Tecnis) with design enhancements that target zero spherical aberration and improve night-driving simulator performance, according to the company.

A 360-degree edge design (ProTec, AMO) provides an uninterrupted barrier edge to minimize cell migration to the posterior capsule. Unlike first-generation, one-piece lenses, the new lens has no interruption at the haptic-optic junction, according to the company. The lens also features a frosted edge to minimize edge glare. In addition, three-point fixation (Tri-Fix, AMO) provides stability. Refraction stabilizes quickly after the implantation procedure.

Made from a hydrophobic acrylic material that blocks ultraviolet light, the lens transmits the blue light needed for improved scotopic vision and healthy circadian rhythms. The IOL's one-piece design and reduced center thickness enable simple implantation with bag-friendly coplanar delivery and gentle unfolding haptics, the company said.

The lens has been designated as a New Technology Intraocular Lens by the Centers for Medicare and Medicaid Services.

For more information, visit AMO at booths 1328 and 1628.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.